Science Explorer Interactive view Map
Company · San Diego · United States

Tracon Pharmaceuticals (United States)

Research works
79
▼ 55% vs 2013–17
Citations
2.7k
34.2 per fractional work
Top-10% rate
39.2%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Tracon Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 10.86× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 11.81× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.45× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.57× its world share, 0 worksChemistryMaterials Science: 0.15× its world share, 0 worksMaterials ScienceMedicine: 1.47× its world share, 3 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 11.8×. Every wedge is a field page.

Who are the top researchers at Tracon Pharmaceuticals (United States)?

Ranked on the composite score, Charles P. Theuer lead among researchers whose main affiliation is Tracon Pharmaceuticals (United States).

  1. 1 Charles P. Theuer United States · #975,123 worldwide 51 citations · 33 works
All ranked researchers at Tracon Pharmaceuticals (United States)

Which keywords describe research at Tracon Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Inflammation, Immunotherapy, Tumor Microenvironment, Tumor Targeting, Breast Cancer and endothelial progenitor cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer8▲ 7.2×19 topics
  2. Inflammation7▲ 3.6×18 topics
  3. Cancer Therapy6▲ 13×12 topics
  4. Immunotherapy4▲ 8.4×12 topics
  5. Nanoparticles4▲ 3.9×5 topics
  6. Tumor Microenvironment4▲ 14×8 topics
  7. Tumor Targeting4▲ 36×3 topics
  8. Breast Cancer3▲ 15×3 topics
  9. Chemotherapy3▲ 5.8×12 topics
  10. Prognostic Factors3▲ 8.2×6 topics
  11. VEGF3▲ 110×1 topic
  12. endothelial progenitor cells3▲ 110×1 topic
  13. Angiogenesis3▲ 8.9×7 topics
  14. Immune Response3▲ 5.9×4 topics
  15. Oxygen Sensing2▲ 22×2 topics
  16. Tumor Hypoxia2▲ 36×2 topics
  17. HIF-12▲ 43×1 topic
  18. Targeted Therapy2▲ 14×4 topics
  19. Warburg Effect2▲ 43×1 topic
  20. Cancer Progression2▲ 12×5 topics
  21. Epithelial-Mesenchymal Transition2▲ 33×3 topics
  22. Metastasis2▲ 8.5×9 topics
  23. Cell Proliferation2▲ 31×3 topics
  24. Metastatic2▲ 44×2 topics
  25. PET Imaging2▲ 13×3 topics
  26. Signal Transduction2▲ 11×3 topics
  27. Drug Delivery2▲ 5.4×3 topics
  28. Cancer Treatment2▲ 8.8×2 topics
  29. Glycosylation2▲ 10×2 topics
  30. HER22▲ 76×1 topic
  31. Metastatic Breast Cancer2▲ 35×2 topics
  32. Trastuzumab2▲ 54×1 topic
  33. Cancer Stem Cells2▲ 49×1 topic
  34. Fisheries Sustainability2▲ 17×2 topics
  35. Oncogenic Mutations2▲ 47×2 topics
  36. Tumor Metastasis2▲ 35×1 topic
  37. BRAF gene2▲ 115×1 topic
  38. Photodynamic Therapy2▲ 13×2 topics
  39. Radioimmunotherapy2▲ 52×1 topic
  40. Radiopharmaceuticals2▲ 52×1 topic

Which research topics does Tracon Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, RNA modifications and cancer and Immune Cell Function and Interaction.

  1. 1 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 RNA modifications and cancer Molecular Biology 1 works
  4. 4 Immune Cell Function and Interaction Immunology 0 works
  5. 5 Immune cells in cancer Immunology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
  8. 8 DNA Repair Mechanisms Molecular Biology 0 works
  9. 9 Microtubule and mitosis dynamics Cell Biology 0 works
  10. 10 Glycosylation and Glycoproteins Research Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.2%not open59.8%

World: 28% of research is openly available.

with international co-authors20.2%domestic only79.8%

World: 19% is written across borders.

How has Tracon Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 55% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.